Enzymotec Ltd. To Present at Two Upcoming Investor Conferences

- August 2nd, 2016

August 02, 2016 08:30 ET | Source:Enzymotec Ltd. MIGDAL HA’EMEQ, Israel, Aug. 02, 2016 (GLOBE NEWSWIRE) — Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and medical foods, announced today that Dr. Ariel Katz, the Company’s Chief Executive Officer, is scheduled to present at the Jefferies Industrial Conference, … Continued

| Source:Enzymotec Ltd.


MIGDAL HA’EMEQ, Israel, Aug. 02, 2016 (GLOBE NEWSWIRE) — Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and medical foods, announced today that Dr. Ariel Katz, the Company’s Chief Executive Officer, is scheduled to present at the Jefferies Industrial Conference, being held August 9 – 11, 2016 in New York City and the Canaccord Genuity Annual Growth Conference, being held August 10 – 11, 2016 in Boston.

Details for the Company presentation are as follows:

Conference: Jefferies Industrial Conference
Date: Wednesday, August 10, 2016
Time: 10:40AM ET
Conference: Canaccord Genuity Annual Growth Conference
Date: Thursday, August 11, 2016
Time: 10:30AM ET

About Enzymotec Ltd.

Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures, and markets innovative bio-active lipid based nutritional ingredients and medical foods, driven by a deep core of cutting-edge, proprietary technologies intended to improve people’s health.  For more information, visit www.enzymotec.com.

Contact:
The Ruth Group
Tram Bui / Lee Roth
(646) 536-7035/7012
tbui@theruthgroup.com
lroth@theruthgroup.com

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select None
Select All

Leave a Reply